Activist investor Carl Icahn has signaled he wants former CEO Jay Flatley to return to gene-sequencing test maker.
Source link
Tags: acquisitions, Acquisitions/Mergers/Shareholdings, Anti-Competition Issues, Biotechnology Services, C&E Executive News Filter, C&E Industry News Filter, Carl Icahn, Content Types, corporate, Corporate Actions, Corporate Governance, Corporate/Industrial News, environmental, Environmental/Social/Governance, Factiva Filters, Genomics, governance, government policy, healthcare, Healthcare/Life Sciences, Illumina, ILMN, industrial news, life sciences, Management, Management Moves, mergers, Ownership Changes, Proxy Fight, regulation, Regulation/Government Policy, Senior Level Management, Shareholder Activism, shareholdings, social, SYND, WSJ-PRO-WSJ.com, wsjhealth
